A difficult-to-treat pleuropulmonary histoplasmosis in a patient with rheumatoid arthritis in Taiwan

被引：1

作者：

Chu, Wen -Kai ^{[1
]}

Wu, Un-In ^{[1
,2
]}

Lee, Tai-Fen ^{[3
]}

Cheng, Aristine ^{[1
]}

Chen, Kai -Hsiang ^{[1
]}

Lin, Kuan-Yin ^{[1
,4
]}

Chen, Yee-Chun ^{[1
]}

机构：

[1] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan

[2] Natl Taiwan Univ Canc Ctr, Dept Med, Taipei, Taiwan

[3] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan

[4] Natl Taiwan Univ Hosp, Dept Internal Med, 7 Chung Shan South Rd, Taipei, Taiwan

来源：

JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION | 2023年 / 56卷 / 01期

关键词：

Histoplasma capsulatum; Rheumatoid arthritis; Salvage treatment; Voriconazole; Posaconazole; Non-endemic area; ANTIFUNGAL SUSCEPTIBILITY; MANAGEMENT; SOCIETY;

D O I：

10.1016/j.jmii.2022.12.005

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Amphotericin B and itraconazole are the primary agents for treating histoplasmo-sis. Newer azoles are alternatives for patients refractory to or intolerant of standard therapy. We report an 83-year-old woman with rheumatoid arthritis complicated with pleuropulmonary histoplasmosis who responded to liposomal amphotericin B, but progressed under voriconazole and posaconazole maintenance therapy.Copyright (c) 2022, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

引用

页码：192 / 196

页数：5

共 50 条

[11] CHARACTERISTICS OF PATIENTS WITH DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS IN FRANCE
Hecquet, S.
Combier, A.
Steelandt, A.
Pons, M.
Wendling, D.
Molto, A.
Richard, C. Miceli
Allanore, Y.
Avouac, J.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 181 - 182
[12] Difficult-to-treat psoriatic arthritis: moving out of the rheumatoid arthritis shadow
Siebert, Stefan
Marzo-Ortega, Helena
[J]. NATURE REVIEWS RHEUMATOLOGY, 2024, 20 (03) : 135 - 136
[13] Difficult-to-treat psoriatic arthritis: moving out of the rheumatoid arthritis shadow
Stefan Siebert
Helena Marzo-Ortega
[J]. Nature Reviews Rheumatology, 2024, 20 : 135 - 136
[14] Characteristics of Difficult-to-Treat Rheumatoid Arthritis: Results of an International Survey
Roodenrijs, Nadia M. T.
de Hair, Maria J. H.
van der Goes, Marlies C.
Jacobs, Johannes W. G.
Welsing, Paco M. J.
van der Heijde, Desiree
Aletaha, Daniel
Dougados, Maxime
Hyrich, Kimme L.
McInnes, Iain B.
Mueller-Ladner, Ulf
Senolt, Ladislav
Szekanecz, Zoltan
van Laar, Jacob
Nagy, Gyorgy
[J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
[15] A paradigm of difficult-to-treat rheumatoid arthritis: subtypes and early identification
Novella-Navarro, M.
Ruiz-Esquide, V.
Torres-Ortiz, G.
Chacur, C. A.
Tornero, C.
Fernandez-Fernandez, E.
Monjo, I.
Sanmarti, R.
Plasencia-Rodriguez, C.
Balsa, A.
[J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (05) : 1114 - 1119
[16] Characteristics of patients with difficult-to-treat rheumatoid arthritis in clinical practice
Takanashi, Satoshi
Kaneko, Yuko
Takeuchi, Tsutomu
[J]. RHEUMATOLOGY, 2021, 60 (11) : 5247 - 5256
[17] Switching from prednisolone to dexamethasone in difficult-to-treat rheumatoid arthritis
Kerstens, Floor
Spijkers, Karin
Wolthuis, David
Boers, Maarten
van Herwaarden, Noortje
ten Cate, David
[J]. RHEUMATOLOGY, 2024, 63 (01): : e15 - e16
[18] CHARACTERISTICS OF DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS: RESULTS OF AN INTERNATIONAL SURVEY
Roodenrijs, N. M. T.
de Hair, M. J. H.
Jacobs, J. W. G.
Welsing, P. M. J.
van der Heijde, D. M. F. M.
van Laar, J. M.
Nagy, G.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 120 - 120
[19] DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS: A BIOMARKER SCREENING PILOT STUDY
Baloun, J.
Pekacova, A.
Mann, H.
Vencovsky, J.
Pavelka, K.
Senolt, L.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1062 - 1063
[20] Non-pharmacological treatment in difficult-to-treat rheumatoid arthritis
Majnik, Judit
Csaszar-Nagy, Noemi
Bocskei, Georgina
Bender, Tamas
Nagy, Gyorgy
[J]. FRONTIERS IN MEDICINE, 2022, 9

← 1 2 3 4 5 →